Please assess the completion status of the following clinical trial:

Trial Title: Median Nerve Stimulation Pilot

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 15-64 inclusive at initial screening visit~* Informed consent by adult subject; assent by child and informed consent by guardian~* Current Tourette's Disorder or Persistent (Chronic) Tic Disorder according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition: DSM-5~* At least 1 tic per minute (average) during the first 5-min. baseline video session on the first visit (as scored during the session by the investigator)~Exclusion Criteria:~* Unable to complete study procedures for any reason~* Has an implanted device that could be affected by electrical current~* Pregnancy known to participant or (for children) to the parent~* Known or suspected primary genetic syndrome (e.g. Down syndrome, Fragile X)~* Intellectual disability (known, or likely from history and examination)~* Head trauma with loss of consciousness for more than 5 minutes~* Significant neurologic disease, not counting TS (exceptions include febrile seizures or uncomplicated migraine)~* Severe or unstable systemic illness~* Factors (such as exaggerated signs) that in the judgment of the principal investigator make the video recording or YGTSS an inaccurate assessment of tic severity~* Judged by investigator to be unlikely to complete study procedures or to return for later visits~* Change in somatic or psychotherapeutic treatment in the 2 weeks preceding the first stimulation visit~* Planned change in somatic or psychotherapeutic treatment between the 2 stimulation visits

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Experimental: rhythmic MNS, then arrhythmic MNS (Type: OTHER): Participants will complete two stimulation sessions, at least a week apart. The first session involves rhythmic MNS and the second uses arrhythmic MNS.
- Experimental: arrhythmic MNS, then rhythmic MNS (Type: OTHER): Participants will complete two stimulation sessions, at least a week apart. The first session involves arrhythmic MNS and the second uses rhythmic MNS.

Based on this trial design, predict the completion outcome and termination type (if applicable).